The relationship between peripheral neuropathy and efficacy in second-line chemotherapy for unresectable advanced gastric cancer: a prospective observational multicenter study protocol (IVY)

BACKGROUND: Paclitaxel is used in second-line conventional chemotherapies to manage patients with unresectable advanced gastric cancer (GC). Paclitaxel-induced peripheral neuropathy is a known adverse event leading to treatment discontinuation. Additionally, oxaliplatin which causes irreversible per...

Descripción completa

Detalles Bibliográficos

Autores principales:	Tanioka, Hiroaki, Nagasaka, Takeshi, Uno, Futoshi, Inoue, Masafumi, Okita, Hiroyuki, Katata, Yosuke, Kanzaki, Hiromitsu, Kuramochi, Hidekazu, Satake, Hironaga, Shindo, Yoshiaki, Doi, Akira, Nasu, Jyunichiro, Yamashita, Haruhiro, Yamaguchi, Yoshiyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788076/ https://www.ncbi.nlm.nih.gov/pubmed/31604467 http://dx.doi.org/10.1186/s12885-019-6163-6